Efficacy of EUS-guided Celiac Plexus Blockade in Chronic Pancreatitis
Completed · Phase 3
Conditions studied: Chronic Pancreatitis
In brief
This is a triple-blind, parallel group, randomized controlled trial to assess the benefit of triamcinolone injection as a therapeutic measure for control of chronic pancreatitis pain. The treatment group will undergo EUS-CPB with bupivicaine plus triamcinolone ("therapeutic block"). There control group will undergo EUS-CPB with bupivicaine alone ("diagnostic block").
Key facts
- Study ID
- NCT00658736
- Run by
- The Cleveland Clinic
- People needed
- 40
- Starts
- 2008-03-01
- Expected to finish
- 2011-01-01
- Last updated by the study team
- 2017-06-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cleveland Clinic Foundation — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.